Transcript data not available for CHSCO Q2 2026. No direct management quotes can be provided from the earnings call data.
— CHS Management
03Detailed Report
CHSCO
Company CHSCO
Period
Q2 2026
CurrencyUSD
Report TypeQuarterly Earnings
GeneratedJun 27, 2026
Swipe to view all report sections
Executive Summary
CHS Inc reported QQ2 2026 revenue of $8.3539 billion but posted a sharply contracted gross profit of $25.8 million, yielding a gross margin of 0.31%. EBITDA and operating income were negative at $(241.8) million, and net income came in at $(147.1) million, marking a material deterioration versus the prior-year period. The revenue base remained flat-to-down versus peers, yet profitability collapsed due to an unusually tight cost of revenue relative to revenue, contributing to negative operating leverage across the four segments (Energy, Ag Nitrogen, Production, and Foods). Cash and equivalents stood at $248.5 million against total debt of $4.13 billion and net debt of about $3.88 billion, with liquidity metrics showing a moderate current cushion but weaker quick liquidity indicators due to high working capital in inventory and receivables. Management commentary in the earnings cycle is essential to understand whether margin compression reflects temporary market volatility or a longer-duration structural shift in CHS’s integrated model.
Key Performance Indicators
Revenue
Decreasing
8.35B
QoQ: -5.76% | YoY: -10.12%
Gross Profit
Decreasing
25.82M
0.31% margin
QoQ: -93.37% | YoY: -93.56%
Operating Income
Decreasing
-241.79M
QoQ: -294.00% | YoY: -275.43%
Net Income
Decreasing
-147.05M
QoQ: -156.45% | YoY: -160.07%
Revenue Trend
Margin Analysis
Financial Highlights
Revenue performance: QQ2 2026 revenue of $8.3539B, down -5.76% QoQ and down -10.12% YoY. Gross Profit: $25.818M, margin 0.31%, down -93.56% YoY and -93.37% QoQ, indicating severe compression in core profitability. Operating Income: $(241.791)M, margin $(2.89)% (EBITDA: $(241.791)M, EBITDARatio $(0.0289)); YoY and QoQ declines reflect intensified cost of revenue and pricing dynamics. Net Income: $(147.052)M, margin $(1.76)% (YoY: -160.07%, QoQ: -156.45%). Earnings per share: not disclosed in the data. Balance sheet health: Cash and cash equivalents $248.5M; Total current assets $10.256B; Total assets $20.909B; Total current liabilities $7.081B; Total liabilities $9.065B; Total stockholders’ equity $11.843B. Leverage and liquidity: Short-term debt $2.144B; Long-term debt $1.984B; Net debt $3.879B; Current ratio ~1.45; Quick ratio ≈ 0.54 (cash plus net receivables vs current liabilities), suggesting tighter near-term liquidity absent favorable working capital movements. Cash flow signal: EBITDA negative, indicating operating deleveraging pressure; detailed cash flow from operations not provided in the dataset.
Income Statement
Metric
Value
YoY Change
QoQ Change
Revenue
8.35B
-10.12%
-5.76%
Gross Profit
25.82M
-93.56%
-93.37%
Operating Income
-241.79M
-275.43%
-294.00%
Net Income
-147.05M
-160.07%
-156.45%
Key Financial Ratios
Management Insights Available for Members
Get exclusive access to management commentary, earnings call quotes, and forward guidance from company leadership.